{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:43Z","timestamp":1794047503402,"version":"4.8.0"},"reference-count":50,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"8","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Although chronic lymphocytic leukemia (CLL) is diagnosed by identifying a circulating B-cell clone that exceeds 5x103\/\u03bcL, additional distinct clones (ADC) have been identified in various studies. Notably, the numbers of ADC documented in these studies has increased as the various technologies evolved. To better define the frequency and the characteristics of ADC in CLL, we used a next-generation sequencing platform that affords high sequencing depth along with steps that limit overcounting to analyze IGHV-IGHD-IGHJ gene rearrangements in circulating CD5+ B cells from 57 patients. Notably, all patients had at least one ADC, in addition to the clinically relevant clone. In 46 patients for whom lymphocyte count data were available, 44 had at least one ADC above the threshold of 1 B cell\/\u03bcL and, remarkably, the average number of ADC was 12 per patient. Notably, in two patients, the predominant ADC qualified clinically as a separate CLL clone and in the remaining cases as low\/high-count monoclonal B-cell lymphocytosis clones. Moreover, in 11 patients studied longitudinally, predominant ADC were persistent and often increased in number. ADC in patients with CLL exhibited 4-fold more stereotyped IGHV-IGHD-IGH rearrangements than found in CD5+ B cells from healthy individuals, and IGHV use, somatic mutations, and Ig isotype distribution were similar between predominant ADC and clinically relevant clones. Thus, finding multiple expanded clones within the CD5+ B cells is the rule in patients with CLL, indicating that leukemogenesis is a multiclonal process that likely involves competition among B cells with special B-cell receptor features.<\/jats:p>","DOI":"10.3324\/haematol.2024.286380","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T03:14:17Z","timestamp":1740021257000},"page":"1747-1757","source":"Crossref","is-referenced-by-count":5,"title":["Chronic lymphocytic leukemia often arises by a multiclonal selection process"],"prefix":"10.3324","volume":"110","author":[{"given":"Davide","family":"Bagnara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea N.","family":"Mazzarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Cardente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddha","family":"Kasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ghiotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline C.","family":"Barrientos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Kolitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanti R.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Alen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Fais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manlio","family":"Ferrarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Chiorazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"77279","doi-asserted-by":"crossref","unstructured":"Rai KR, Jain P. Chronic lymphocytic leukemia (CLL)-then and now. Am J Hematol. 2016; 91(3):330-340.","DOI":"10.1002\/ajh.24282"},{"key":"77280","doi-asserted-by":"crossref","unstructured":"Hallek M. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. Am J Hematol. 2019; 94(11):1266-1287.","DOI":"10.1002\/ajh.25595"},{"key":"77281","doi-asserted-by":"crossref","unstructured":"Stevenson FK, Forconi F, Kipps TJ. Exploring the pathways to chronic lymphocytic leukemia. Blood. 2021; 138(10):827-835.","DOI":"10.1182\/blood.2020010029"},{"key":"77282","doi-asserted-by":"crossref","unstructured":"Bagnara D, Mazzarello AN, Ghiotto F. Old and new facts and speculations on the role of the B cell receptor in the origin of chronic lymphocytic leukemia. Int J Mol Sci. 2022; 23(22):14249.","DOI":"10.3390\/ijms232214249"},{"key":"77283","doi-asserted-by":"crossref","unstructured":"Plevova K, Francova HS, Burckova K. Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clones. Haematologica. 2014; 99(2):329-338.","DOI":"10.3324\/haematol.2013.087593"},{"key":"77284","doi-asserted-by":"crossref","unstructured":"Brazdilova K, Plevova K, Francova HS. Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL. Leukemia. 2018; 32(1):234-236.","DOI":"10.1038\/leu.2017.274"},{"key":"77285","doi-asserted-by":"crossref","unstructured":"Kriangkum J, Motz SN, Mack T. Single-cell analysis and next-generation immuno-sequencing show that multiple clones persist in patients with chronic lymphocytic leukemia. PloS One. 2015; 10(9):e0137232.","DOI":"10.1371\/journal.pone.0137232"},{"key":"77286","doi-asserted-by":"crossref","unstructured":"Stamatopoulos B, Timbs A, Bruce D. Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia. Leukemia. 2017; 31(4):837-845.","DOI":"10.1038\/leu.2016.307"},{"key":"77287","doi-asserted-by":"crossref","unstructured":"Klinger M, Zheng J, Elenitoba-Johnson KSJ, Perkins SL, Faham M, Bahler DW. Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation. Leukemia. 2016; 30(5):1055-1061.","DOI":"10.1038\/leu.2015.351"},{"key":"77288","doi-asserted-by":"crossref","unstructured":"Hashimoto S, Dono M, Wakai M. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med. 1995; 181(4):1507-1517.","DOI":"10.1084\/jem.181.4.1507"},{"key":"77289","doi-asserted-by":"crossref","unstructured":"Fais F, Ghiotto F, Hashimoto S. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998; 102(8):1515-1525.","DOI":"10.1172\/JCI3009"},{"key":"77290","doi-asserted-by":"crossref","unstructured":"Damle RN, Wasil T, Fais F. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999; 94(6):1840-1847.","DOI":"10.1182\/blood.V94.6.1840.418k06_1840_1847"},{"key":"77291","doi-asserted-by":"crossref","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999; 94(6):1848-1854.","DOI":"10.1182\/blood.V94.6.1848.418k05_1848_1854"},{"key":"77292","doi-asserted-by":"crossref","unstructured":"Ghiotto F, Fais F, Valetto A. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest. 2004; 113(7):1008-1016.","DOI":"10.1172\/JCI19399"},{"key":"77293","doi-asserted-by":"crossref","unstructured":"Widhopf GF, Rassenti LZ, Toy TL, Gribben JG, Wierda WG, Kipps TJ. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood. 2004; 104(8):2499-2504.","DOI":"10.1182\/blood-2004-03-0818"},{"key":"77294","doi-asserted-by":"crossref","unstructured":"Messmer BT, Albesiano E, Efremov DG. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med. 2004; 200(4):519-525.","DOI":"10.1084\/jem.20040544"},{"key":"77295","doi-asserted-by":"crossref","unstructured":"Tobin G, Thunberg U, Karlsson K. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood. 2004; 104(9):2879-2885.","DOI":"10.1182\/blood-2004-01-0132"},{"key":"77296","doi-asserted-by":"crossref","unstructured":"Agathangelidis A, Chatzidimitriou A, Gemenetzi K. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. Blood. 2020; 137(10):1365-1376.","DOI":"10.1182\/blood.2020007039"},{"key":"77297","doi-asserted-by":"crossref","unstructured":"Minden MD, Wossning T, Surova E, Follo M, K\u00f6hler F, Jumaa H. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature. 2012; 489(7415):309-312.","DOI":"10.1038\/nature11309"},{"key":"77298","doi-asserted-by":"crossref","unstructured":"Burger JA. Treatment of chronic lymphocytic leukemia. N Engl J Med. 2020; 383(5):460-473.","DOI":"10.1056\/NEJMra1908213"},{"key":"77299","doi-asserted-by":"crossref","unstructured":"Marsilio S, Khiabanian H, Fabbri G. Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: documentation and cautionary note regarding cell fraction purity. Leukemia. 2018; 32(4):1041-1044.","DOI":"10.1038\/leu.2017.343"},{"key":"77300","doi-asserted-by":"crossref","unstructured":"Damm F, Mylonas E, Cosson A. Acquired initiating mutations in early hematopoietic cells of CLL patients. Cancer Discov. 2014; 4(9):1088-1101.","DOI":"10.1158\/2159-8290.CD-14-0104"},{"key":"77301","doi-asserted-by":"crossref","unstructured":"Agathangelidis A, Ljungstr\u00f6m V, Scarf\u00f2 L. Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations. Haematologica. 2018; 103(5):865-873.","DOI":"10.3324\/haematol.2017.177212"},{"key":"77302","doi-asserted-by":"crossref","unstructured":"Goldin LR, Slager SL, Caporaso NE. Familial chronic lymphocytic leukemia. Curr Opin Hematol. 2010; 17(4):350-355.","DOI":"10.1097\/MOH.0b013e328338cd99"},{"key":"77303","doi-asserted-by":"crossref","unstructured":"Vergani S, Korsunsky I, Mazzarello AN, Ferrer G, Chiorazzi N, Bagnara D. Novel method for high-throughput full-length IGHV-D-J sequencing of the immune repertoire from bulk B-cells with single-cell resolution. Front Immunol. 2017; 14(8):1157.","DOI":"10.3389\/fimmu.2017.01157"},{"key":"77304","doi-asserted-by":"crossref","unstructured":"Bagnara D, Tang C, Brown JR. Post-transformation IGHV-IGHD-IGHJ mutations in chronic lymphocytic leukemia B cells: implications for mutational mechanisms and impact on clinical course. Front Oncol. 2021; 25(11):640731.","DOI":"10.3389\/fonc.2021.640731"},{"key":"77305","doi-asserted-by":"crossref","unstructured":"Heiden JAV, Yaari G, Uduman M. pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires. Bioinformatics. 2014; 30(13):1930-1932.","DOI":"10.1093\/bioinformatics\/btu138"},{"key":"77306","unstructured":"Alamyar E, Giudicelli V, Li S, Duroux P, Lefranc M-P. IMGT\/ HighV-QUEST: the IMGT web portal for immunoglobulin (Ig) or antibody and T cell receptor (TR) analysis from NGS high throughput and deep sequencing. Immunome Res. 2012; 8(1):26."},{"key":"77307","doi-asserted-by":"crossref","unstructured":"Gupta NT, Heiden JAV, Uduman M, Gadala-Maria D, Yaari G, Kleinstein SH. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics. 2015; 31(20):3356-3358.","DOI":"10.1093\/bioinformatics\/btv359"},{"key":"77308","doi-asserted-by":"crossref","unstructured":"Bystry V, Agathangelidis A, Bikos V. ARResT\/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy. Bioinformatics. 2015; 31(23):3844-3846.","DOI":"10.1093\/bioinformatics\/btv456"},{"key":"77309","doi-asserted-by":"crossref","unstructured":"Bagnara D, Colombo M, Reverberi D. characterizing features of human circulating B cells carrying CLL-like stereotyped immunoglobulin rearrangements. Front Oncol. 2022; 23(12):894419.","DOI":"10.3389\/fonc.2022.894419"},{"key":"77310","doi-asserted-by":"crossref","unstructured":"Strati P, Shanafelt TD. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. Blood. 2015; 126(4):454-462.","DOI":"10.1182\/blood-2015-02-585059"},{"key":"77311","doi-asserted-by":"crossref","unstructured":"Karube K, Scarf\u00f2 L, Campo E, Ghia P. Monoclonal B cell lymphocytosis and \u201cin situ\u201d lymphoma. Semin Cancer Biol. 2014; 24:3-14.","DOI":"10.1016\/j.semcancer.2013.08.003"},{"key":"77312","doi-asserted-by":"crossref","unstructured":"Rawstron AC, Ssemaganda A, de Tute R. Monoclonal B-cell lymphocytosis in a hospital-based UK population and a rural Ugandan population: a cross-sectional study. Lancet Haematol. 2017; 4(7):e334-e340.","DOI":"10.1016\/S2352-3026(16)30192-2"},{"key":"77313","doi-asserted-by":"crossref","unstructured":"Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol. 1997; 158(1):235-246.","DOI":"10.4049\/jimmunol.158.1.235"},{"key":"77314","doi-asserted-by":"crossref","unstructured":"Kolijn PMM, Hosnijeh FS, Sp\u00e4th F. high-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. Blood. 2022; 139(10):1557-1563.","DOI":"10.1182\/blood.2021012890"},{"key":"77315","doi-asserted-by":"crossref","unstructured":"Rassenti LZ, Kipps TJ. Lack of allelic exclusion in B cell chronic lymphocytic leukemia. J Exp Med. 1997; 185(8):1435-1446.","DOI":"10.1084\/jem.185.8.1435"},{"key":"77316","doi-asserted-by":"crossref","unstructured":"Rossi D, Spina V, Gaidano G. Biology and treatment of Richter syndrome. Blood. 2018; 131(25):2761-2772.","DOI":"10.1182\/blood-2018-01-791376"},{"key":"77317","doi-asserted-by":"crossref","unstructured":"Mao Z, Quintanilla-Martinez L, Raffeld M. IgVH mutational status and clonality analysis of Richter\u2019s transformation. Am J Surg Pathol. 2007; 31(10):1605-1614.","DOI":"10.1097\/PAS.0b013e31804bdaf8"},{"key":"77318","doi-asserted-by":"crossref","unstructured":"Salvetti C, Vitale C, Griggio V. Case report: sequential development of three mature lymphoid neoplasms in a single patient: clonal relationship and molecular insights. Front Oncol. 2022; 12:917115.","DOI":"10.3389\/fonc.2022.917115"},{"key":"77319","doi-asserted-by":"crossref","unstructured":"Don MD, Casiano C, Wang H-Y, Gorbounov M, Song W, Ball ED. A rare case of Richter transformation to both clonally unrelated and clonally related diffuse large B\u2010cell lymphoma in the same patient. Case Rep Hematol. 2024; 2024:7913296.","DOI":"10.1155\/2024\/7913296"},{"key":"77320","doi-asserted-by":"crossref","unstructured":"Cheah CY, Spagnolo D, Frost F, Cull G. Synchronous biphenotypic Richter syndrome with Epstein-Barr virus\u2010positive nodal classical Hodgkin lymphoma and bone marrow diffuse large B\u2010cell lymphoma. Histopathology. 2016; 69(4):707-710.","DOI":"10.1111\/his.12984"},{"key":"77321","doi-asserted-by":"crossref","unstructured":"Bernardo AD, Mussetti A, Aiello A, Paoli ED, Cabras AD. Alternate clonal dominance in Richter transformation presenting as extranodal diffuse large B-cell lymphoma and synchronous classic Hodgkin lymphoma. Am J Clin Pathol. 2014; 142(2):227-232.","DOI":"10.1309\/AJCP4T9RPXYTXQDE"},{"key":"77322","doi-asserted-by":"crossref","unstructured":"Cappione A, Anolik JH, Pugh-Bernard A. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Investig. 2005; 115(11):3205-3216.","DOI":"10.1172\/JCI24179"},{"key":"77323","doi-asserted-by":"crossref","unstructured":"Vergani S, Bagnara D, Agathangelidis A. CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: apparent lack of central and early peripheral tolerance censoring. Front Oncol. 2023; 13(17):1112879.","DOI":"10.3389\/fonc.2023.1112879"},{"key":"77324","doi-asserted-by":"crossref","unstructured":"Zupo S, Isnardi L, Megna M. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood. 1996; 88(4):1365-1374.","DOI":"10.1182\/blood.V88.4.1365.bloodjournal8841365"},{"key":"77325","doi-asserted-by":"crossref","unstructured":"Chen L, Widhopf G, Huynh L. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood. 2002; 100(13):4609-4614.","DOI":"10.1182\/blood-2002-06-1683"},{"key":"77326","doi-asserted-by":"crossref","unstructured":"Lanham S, Hamblin T, Oscier D, Ibbotson R, Stevenson F, Packham G. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood. 2003; 101(3):1087-1093.","DOI":"10.1182\/blood-2002-06-1822"},{"key":"77327","doi-asserted-by":"crossref","unstructured":"Efremov DG, Gobessi S, Longo PG. Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells. Autoimmun Rev. 2007; 7(2):102-108.","DOI":"10.1016\/j.autrev.2007.02.021"},{"key":"77328","doi-asserted-by":"crossref","unstructured":"Muzio M, Apollonio B, Scielzo C. Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood. 2008; 112(1):188-195.","DOI":"10.1182\/blood-2007-09-111344"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/11949\/78084","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11949\/78619","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11949\/78084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:08:13Z","timestamp":1794046093000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/11949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.286380","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,20]]}}}